Treating Blood Cancers

Lori Muffly MD, MS, Stanford Medicine, Stanford, CA

Recorded on May 12, 2026

Lori Muffly MD, MS

Professor of Medicine

Division of Blood and Marrow Transplantation & Cellular Therapy

Stanford Medicine

Stanford, CA

In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next.

Mentioned on this episode:

www.NMDP.org

www.hematology.org

Additional Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Mayra Allen, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Recorded on April 23, 2026

Mayra Allen, PhD

Clinical Psychologist, Psycho-Oncology Service

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, CA

Join us for an insightful conversation with Mayra Allen, PhD, clinical psychologist at UCSF’s Helen Diller Family Comprehensive Cancer Center, as we explore actionable strategies for supporting couples, caregivers, and families navigating cancer care. This episode examines practical communication approaches, the evolving role of care partners, and ways to help families manage complex situations. The discussion also addresses important yet often overlooked topics, including changes in intimacy, the impact of cultural perspectives across the cancer journey, and resources to support clinicians in delivering whole person oncology care. Tune in to this thoughtful discussion today!

Mentioned on this episode:

Caregivers Action Network (CAN)

Family Caregiver Alliance

Women’s Cancer Resource Center

Additional Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

David Sallman, MD, Moffitt Cancer Center, Tampa, FL

Recorded on April 9, 2026

David Sallman, MD

Associate Member, Department of Malignant Hematology

Moffitt Cancer Center

Tampa, FL

In this exciting episode, Dr. David Sallman from Moffitt Cancer Center takes a deep dive into acute myeloid leukemia (AML) and the advances transforming patient care. The discussion spans newly approved therapies, including menin inhibitors, as well as promising approaches under investigation in clinical trials, and explores how these innovations are influencing treatment selection, transplantation, and the management of side effects and complications in today’s AML landscape. Tune in today for expert insight into what’s shaping the future of AML care.

Additional Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

This episode is supported by Kura Oncology, Inc.

Matthew Loscalzo, LCSW, APOS Fellow, City of Hope, Duarte, CA

Recorded on March 30, 2026

Matthew Loscalzo, LCSW, APOS Fellow

Founding Executive Director and Professor Emeritus of Supportive Care Medicine

and Professor of Population Sciences

City of Hope

Duarte, CA

In this episode, licensed clinical social worker Matthew Loscalzo explores how survivors and healthcare professionals often define “normal” differently after treatment. He discusses the emotional shifts that impact relationships, work, and future planning, and shares how healthcare professionals can support meaningful conversations and shared decision-making after treatment ends. Tune in to hear practical insights for supporting patients beyond treatment.

Mentioned on this episode:

Loss and Grief: Personal Stories of Doctors and Other Healthcare Professionals by Linda Klein, Matthew Loscalzo (Editor), Marshall Forstein (Editor)

Additional Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC

Recorded on March 10, 2026

Amy Pierre, MSN, ANP-BC

Senior Clinical Director, Research Oncology, Flatiron Health

Nurse Practitioner, Memorial Sloan Kettering Cancer Center

New York, NY

Peter Voorhees, MD

Director, Outreach for Hematologic Malignancies, Plasma Cells Disorder

Program, Department of Hematologic Oncology and Blood Disorders

Levine Cancer Institute

Charlotte, NC

Professor, Cancer Medicine

Wake Forest University School of Medicine

Winston-Salem, NC

In this episode, Dr. Peter Voorhees from the Levine Cancer Institute and Amy Pierre, MSN, RN, ANP BC from Flatiron Health and Memorial Sloan Kettering, break down the evolving landscape of myeloma, from early signs and diagnostic criteria to frontline therapy, transplant decisions, and T- cell redirecting therapies. They explore real world challenges in survivorship, treatment toxicity, and disparities in access to advanced therapies, offering practical insights to help care teams support patients more effectively. Tune in for an informative and forward looking discussion shaping the future of myeloma management.

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients